Human TIMP-1 ELISA

Product Citations

• Hanedan O. et al. (2016) Evaluation of Cardiovascular Changes in Children with BAVs. Pediatric Cardiology 37(3):472-81. doi: 10.1007/s00246-015-1302-6.
• Prato M. et al. (2016) Effects of oxygen tension and dextran-shelled/2H,3H-decafluoropentane-cored oxygen-loaded nanodroplets on secretion of gelatinases and their inhibitors in term human placenta. Bioscience, Biotechnology, and Biochemistry 80(3):466-72. doi: 10.1080/09168451.2015.1095068
• Basilico N. et al. (2015) Dextran-shelled oxygen-loaded nanodroplets reestablish a normoxia-like pro-angiogenic phenotype and behavior in hypoxic human dermal microvascular endothelium. Toxicology and Applied Pharmacology 288(3):330-8. doi: 10.1016/j.taap.2015.08.005.
• Ciaffi L. et al. (2015) Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study. European Journal of Clinical Investigation 45(7):720-30. doi: 10.1111/eci.12464.
• Garratt L. et al. (2015) Matrix metalloproteinase activation by free neutrophil elastase contributes to bronchiectasis progression in early cystic fibrosis. European Respiratory Journal 46(2):384-94. doi: 10.1183/09031936.00212114.
• ...
Guan W. et al. (2015) Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: Clinical correlates and prognostic implications. Respirology doi: 10.1111/resp.12582
Gulino G. et al. (2015) Oxygen-Loaded Nanodroplets Effectively Abrogate Hypoxia Dysregulating Effects on Secretion of MMP-9 and TIMP-1 by Human Monocytes. Mediators of Inflammation 2015:964838. doi: 10.1155/2015/964838.
Humbert P. et al. (2015) Mecano-Stimulation™ of the skin improves sagging score and induces beneficial functional modification of the fibroblasts: clinical, biological, and histological evaluations. Journal of Clinical Intervations in Aging 10:387-403. doi: 10.2147/CIA.S69752
Khadjavi A. et al. (2015) Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: New insights for chronic wound healing. Toxicology and Applied Pharmacology 286(3):198-206. doi: 10.1016/j.taap.2015.04.015
Markiewicz L. et al. (2015) Altered Expression Levels of MMP1, MMP9, MMP12, TIMP1, and IL-1β as a Risk Factor for the Elevated IOP and Optic Nerve Head Damage in the Primary Open-Angle Glaucoma Patients. Biomed Research International Volume 2015 (2015), Article ID 812503, 8 pages http://dx.doi.org/10.1155/2015/812503
Wadood S. et al. (2015) Variants of MMP-9 and TIMP-1 Levels Could be a Predictor of an Early Development of Cardiovascular Diseases in Type 2 Diabetes among Iraqi Patients. Iraqi Journal of Science Vol 56, No.1C, pp:622-632
Wang W. et al. (2015) The Long-Term Influence of Tissue Inhibitor of Matrix Metalloproteinase-1 in Patients with Mild to Moderate Coronary Artery Lesions in a Chinese Population: A 7-Year Follow-Up Study. Cardiology 132(3):151-8. doi: 10.1159/000430885
Acar, B et al. (2014) Serum MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in multiple sclerosis clinical subtypes and their diagnostic value in the progressive disease course. Biomedical Research Volume 25, Issue 3, Pages 343 - 350. 2014.
Esa S. et al. (2014) Study of the level of sputum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor metalloproteinase-1 (TIMP-1) in COPD patients. Egyptian Journal of Chest Disease and Tuberculosis DOI: 10.1016/j.ejcdt.2014.06.014
Fernandez-Yunquera A. et al. (2014) Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients. World Journal of Transplantation 4(2): 133-140. http://dx.doi.org/10.5500/wjt.v4.i2.133
Ghodpage P. et al. (2014) Influence of phase I periodontal therapy on levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1 . Saudi Dental Journal DOI: 10.1016/j.sdentj.2014.05.003
Gluba-Brzozka A et al. (2014) Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids in Health and Disease doi:10.1186/1476-511X-13-135
Kilic Z. et al. (2014) Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases levels in pediatric patients with congenital heart disease: Relationship to cardiac functions. The Anatolian Journal of Cardiology DOI:10.5152/akd.2014.4950
Koob T. et al. (2014) Cytokines in single layer amnion allografts compared to multilayeramnion/chorion allografts for wound healing. Journal of Biomedical Materials Research Part B: Applied Biomaterials DOI: 10.1002/jbm.b.33265
Popat R. et al. (2014) Gingival crevicular fluid levels of Matrix Metalloproteinase-1 (MMP-1) and Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) in periodontal health and disease. Singapore Dental Journal 35:59-64. doi: 10.1016/j.sdj.2014.07.003.
Rolin G et al. (2014) In vitro study of the impact of mechanical tension on the dermal fibroblast henotype in the context of skin wound healing. Journal of Biomechanics doi.org/10.1016/j.jbiomech.2014.07.015
Tian F. et al. (2014) Urinary Emmprin, MMP-9 and TIMP-1 as potential biomarkers in children with ureteropelvic junction narrowing on conservative treatment. Nephrology doi: 10.1111/nep.12371
Botta et al. (2013) ERK2-regulated TIMP1 induces hyperproliferation of K-Ras(G12D)-transformed pancreatic ductal cells. Neoplasia 15(4):359-372.
Gümüsay, O, et al. (2013) Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B. Hepatology Research
Guzel, Savas, et al. (2013) Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction. The Korean journal of internal medicine
Hampel et al. (2013) Insulin-like Factor 3 Promotes Wound Healing at the Ocular Surface. Endocrinology 154(6):2034-2045.
Omar Mamlouk et al. (2012) Bystander effect in tumor cells produced by Iodine-125 labeled human lymphocytes. International Journal of Radiation Oncology • Biology • Physics 88(12):1019-27. doi: 10.3109/09553002.2012.702297
Raghu H. et al. (2012) uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells. Molecular Oncology 6(1):33-47. doi: 10.1016/j.molonc.2011.11.008.
Yilmax A. et al. (2012) Matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in vesicoureteral reflux. Pediatric Nephrology 27(3):435-41. doi: 10.1007/s00467-011-2026-3.
Moir, L. M, et al. (2011) Doxycycline inhibits matrix metalloproteinase‐2 secretion from TSC2‐null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells. British journal of pharmacology
Yigit, O et al. (2011) The effect of corticosteroid on metalloproteinase levels of nasal polyposis 1. Laryngoscope
Yigit, O, et al. (2011) The effect of corticosteroid on metalloproteinase levels of nasal polyposis 1. Laryngoscope
Upadhyay A. et al. (2009) Role of a LIF antagonist in LIF and OSM induced MMP-1, MMP-3, and TIMP-1 expression by primary articular chondrocytes. Cytokine 46:332-338.
Steed et al. (2008) Amnion-derived Cellular Cytokine Solution A Physiological Combination of Cytokines for Wound Healing. Eplasty 8:e18.
Kralisch et al. (2006) Tissue inhibitor of metalloproteinase 1 expression and secretion are induced by beta-adrenergic stimulation in 3T3-L1 adipocytes. Journal of Endocrinology 189:665-670.
See all product citations